Skip to content
Log in
Sponsored Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt

Author

Seyed Mohammad Taghdisi

h-index 65 View on Semantic Scholar

We have 4 of 361 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Melatonin@Exosome hydrogel composed of chitosan and hyaluronic acid: A promising dressing for wound healing based on exosome therapy.

Wounds pose a significant challenge to both healthcare and the economy, as current therapies often fail to address the complex biology of healing. Exosomes derived from fetal tissue, enriched with regenerative microRNAs and proteins, have demonstrated strong potential in promoting wound repair. Melatonin is an indoleam...

Azar M. Bazzaz, Alireza Karimi, Ali Khoshnood et al. · 0 citations
Open access Sep 2026

Preparation of oxygen-filled adipose-derived stem cells exosome-nanobubbles gel for ultrasound-assisted full-thickness wound healing in rats.

In a rat full-thickness skin defect model, the combined Gel-Exo-NB and Gel-Exo-NB + US treatments achieved the highest wound-closure rate among all groups, with enhanced re-epithelialization, a reduced scar index, elevated CD31 and α-SMA expression, increased fibroblast proliferation, and increased blood vessel formati...

Elnaz Bagheri, Elahehsadat Aminyazdi, Sara Amel et al. · 0 citations
Aug 2026

CRISPR/Cas12a-based tag-free fluorescent biosensor using G-quadruplex specific thioflavin T for detection of oncogenic microRNAs.

Tag-free fluorescence biosensing platform for the detection of circulating miRs in serum, targeting microRNA-21 (miR-21) and microRNA-10b (miR-10b) as clinically relevant oncogenic markers, and demonstrates excellent sequence discrimination capability.

Sepideh Hassibian, Masoomeh Esmaelpourfarkhani, M. Alibolandi et al. · 0 citations
Review Jul 2026

Therapeutic platforms for cancer management centered on blocking the PD-L1/PD-1 interaction through the use of aptamers: A review.

A comprehensive analysis of aptamer-driven strategies aimed at inhibiting the PD-1/PD-L1 immune checkpoint pathway is provided, summarizes recent advances in the design of PD-1/PD-L1-targeted aptamer systems and evaluates their potential to enhance therapeutic efficacy while addressing challenges related to immune resi...

Abolfazl Marvizadeh, Elham Sameiyan, Amir Teymour Najjarkar et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.